Blue Fin Capital’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.27M | Buy |
+10,056
| New | +$1.27M | 0.22% | 68 |
|
2024
Q4 | $1.36M | Sell |
10,319
-160
| -2% | -$21.2K | 0.25% | 64 |
|
2024
Q3 | $1.53M | Sell |
10,479
-37
| -0.4% | -$5.39K | 0.29% | 59 |
|
2024
Q2 | $1.44M | Buy |
10,516
+74
| +0.7% | +$10.2K | 0.29% | 60 |
|
2024
Q1 | $1.43M | Sell |
10,442
-301
| -3% | -$41.3K | 0.32% | 56 |
|
2023
Q4 | $1.46M | Sell |
10,743
-544
| -5% | -$73.9K | 0.37% | 54 |
|
2023
Q3 | $1.38M | Sell |
11,287
-554
| -5% | -$67.7K | 0.4% | 57 |
|
2023
Q2 | $1.5M | Buy |
11,841
+260
| +2% | +$33K | 0.43% | 53 |
|
2023
Q1 | $1.51M | Buy |
11,581
+288
| +3% | +$37.5K | 0.49% | 47 |
|
2022
Q4 | $1.48M | Sell |
11,293
-275
| -2% | -$36.1K | 0.54% | 48 |
|
2022
Q3 | $1.35M | Sell |
11,568
-492
| -4% | -$57.5K | 0.51% | 51 |
|
2022
Q2 | $1.42M | Buy |
12,060
+589
| +5% | +$69.3K | 0.5% | 52 |
|
2022
Q1 | $1.49M | Sell |
11,471
-4,566
| -28% | -$595K | 0.43% | 56 |
|
2021
Q4 | $2.45M | Buy |
16,037
+3,721
| +30% | +$568K | 0.68% | 38 |
|
2021
Q3 | $1.99M | Buy |
12,316
+1,504
| +14% | +$243K | 0.61% | 42 |
|
2021
Q2 | $1.77M | Buy |
10,812
+112
| +1% | +$18.3K | 0.55% | 46 |
|
2021
Q1 | $1.61M | Buy |
10,700
+720
| +7% | +$108K | 0.55% | 50 |
|
2020
Q4 | $1.51M | Buy |
9,980
+1,030
| +12% | +$156K | 0.54% | 50 |
|
2020
Q3 | $1.21M | Sell |
8,950
-580
| -6% | -$78.5K | 0.49% | 52 |
|
2020
Q2 | $1.3M | Buy |
9,530
+3,222
| +51% | +$440K | 0.58% | 47 |
|
2020
Q1 | $679K | Buy |
6,308
+154
| +3% | +$16.6K | 0.37% | 70 |
|
2019
Q4 | $737K | Buy |
6,154
+806
| +15% | +$96.5K | 0.35% | 78 |
|
2019
Q3 | $532K | Sell |
5,348
-400
| -7% | -$39.8K | 0.28% | 85 |
|
2019
Q2 | $627K | Buy |
5,748
+351
| +7% | +$38.3K | 0.32% | 80 |
|
2019
Q1 | $603K | Buy |
5,397
+1,967
| +57% | +$220K | 0.32% | 81 |
|
2018
Q4 | $330K | Sell |
3,430
-1,566
| -31% | -$151K | 0.2% | 104 |
|
2018
Q3 | $609K | Buy |
+4,996
| New | +$609K | 0.3% | 77 |
|